Not yet recruitingPhase 2NCT07373301

Phase IIa/b Trial of PvCS/Montanide ISA-51 Malaria Vaccine in Adults in Chocó, Colombia

Studying Malaria

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Malaria Vaccine and Drug Development Center
Principal Investigator
Myriam Arevalo, PhD
Malaria Vaccine and Drug Development Center (MVDC)
Intervention
PvCS/Montanide ISA-51 VG Vaccine(biological)
Enrollment
72 target
Eligibility
18-50 years · All sexes
Timeline
2026 – 2028

Study locations (1)

Collaborators

Johns Hopkins University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07373301 on ClinicalTrials.gov

Other trials for Malaria

Additional recruiting or active studies for the same condition.

See all trials for Malaria →

← Back to all trials